SLSergey A. Lazarev

Sergey A. Lazarev

*This is an algorithmically generated author record based on publicly available information.

Sergey A. Lazarev has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors

    by Alexander F. Lazarev, Valentina D. Petrova, Sergey A. Lazarev, Zhanna I. Vakhlova, Maria G. Nikolaeva, Tatyana V. Repkina, Svetlana A. Terekhova, Ilya S. Osipov, Evgenia V. Shlyaptseva, Anna N. Komarova, et al.

    BACKGROUND: To date, there are no effective methods for early diagnosis and screening of breast cancer. High-tech methods, such as magnetic resonance imaging and contrasted computed tomography, as well as positron emission computed tomography have high resolution, but their high cost does not allow the use of these techniques for screening and primary diagnosis. AIM: To improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach based on an analysis of a set of risk factors. MATERIALS AND METHODS: Data from the population cancer registry of the Altai Territory, created at the Altai Regional Oncology Center (Barnaul, Russia), were used. To date, the register includes information on 308 550 patients with malignant neoplasms, including 31 783 women with breast cancer. Based on the method of targeted prevention by A.F. Lazarev “Method for determining the risk of breast cancer according to Lazarev A.F.” (Patent No. 2651131) an “Automated program for early diagnosis of breast cancer” was developed. The program significantly reduces the time for the formation of groups of high cancer risk precancers and increases the efficiency of breast cancer detection, and also makes it possible to develop a set of targeted preventive measures personally for each patient. Testing of this algorithm included testing of 512 patients, as a result of which a high-risk precancer group was formed. In the established register, patients underwent a complex of in-depth examinations (ultrasound examination, mammography, magnetic resonance imaging with dynamic contrast, and puncture of tumors if indicated). RESULTS: The precancer group at high risk of developing breast cancer consisted of 92 patients, in-depth examination revealed 7 patients with established breast cancer, which amounted to 7.6%. All cases of breast cancer were detected in stages I and II. CONCLUSION: Targeted diagnostics using the “Automated program for early diagnosis of breast cancer” allows to improve the quality and efficiency of diagnostic measures for breast cancer identification through personalized approach, using multiple risk factors.

  • Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors

    by Alexander F. Lazarev, Valentina D. Petrova, Sergey A. Lazarev, Tatiana V. Repkina, Svetlana A. Terekhova, Pavel A. Obеremok, Ilya S. Osipov, Maria G. Nikolaeva, Dmitriy I. Ganov

    BACKGROUND: There is a trend of increasing incidence and mortality from prostate cancer. Existing methods for early diagnosis and screening of prostate cancer did not demonstrate enough efficiency. AIM: To improve the quality and efficiency of diagnostic measures for prostate cancer through a personalized approach to patients based on an analysis of a set of risk factors. MATERIALS AND METHODS: The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308 550 patients with malignant neoplasms, including 15 167 males with prostate cancer. On the basis of the method of prostate cancer risk assessment proposed by Lazarev AF an automated program for early diagnosis of prostate cancer has been developed. Testing of this technique included assessment of 532 patients (aged between 23 and 82). RESULTS: 128 patients were determined to belong to the high risk pre-cancer group. A high-risk precancer registry was created, which included the patients having individual risk of developing prostate cancer either increased or high or absolute. Upon a set of in-depth examinations, 7 of 128 patients (9.3%) were diagnosed with prostate cancer, all at early stages (I or II). Thus, the incidence of prostate cancer among the patients from the high risk pre-cancer registry was significantly higher than the average observed during prophylactic examinations (0.01%). CONCLUSION: The automated program for early diagnosis of prostate cancer could be implemented with the aim to assign in-depth examination in more targeted manner to patients at high risk of prostate cancer and to contribute to detection the cancer in the early stages.

  • Digital technologies in prostate cancer prevention and early diagnosis

    by A. F. Lazarev, Valentina D. Petrova, V. P. Pokornyak, S. A. Lazarev, V. A. Marchkov, D. I. Ganov

    Background. Prostate cancer is one of the most common malignant neoplasms in males. The Russian Federation observed the same patterns: the incidence of prostate cancer is steadily growing, without the tendency to decrease. Currently, no effective methods are available for prostate cancer early diagnosis and screening. Aim. To improve the effectiveness of prostate cancer prevention and early diagnosis with new digital technologies for high-risk cancer group formation Material and methods. Data from the Cancer Registry population in the Altai regional cancer center, Barnaul City was used. The Cancer Registry includes information about 253,000 patients with malignant neoplasms, including 14,482 males suffering from prostate cancer. Based on the targeted prevention method of A.F. Lazarev, Method for determining the risk of prostate cancer (Patent 2692987) and Automated program for early diagnosis of prostate cancer (certificate of state registration of the computer program No. 2019663514) was developed, which simplifies the stage of forming groups of precancerous high oncorisk and increases prostate cancer detection, as well as develops personalized targeted preventive measures for each patient. Results. The study formed a group of 328 patients with precancerous high oncorisk for prostate cancer in the Cancer Registry, wherein an in-depth examination revealed 26 patients with prostate cancer, which was 7.9%. Stages I and II were established in 97.8%. Conclusion. The web application Automated program for early diagnosis of prostate cancer allows the group formation of high-risk patients who are a targeted search for prostate cancer. The testing process allows a large number of patients to be examined in a short time. The automated program for the early diagnosis of prostate cancer allows a statistically significant increased prostate cancer detection, as well as personalized preventive measure suggestions for each patient.